{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:52:30Z","timestamp":1783511550318,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"MRC(UK)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1447-9","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T20:38:17Z","timestamp":1457383097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["C-reactive protein, Neopterin and Beta2 microglobulin levels pre and post TB treatment in The Gambia"],"prefix":"10.1186","volume":"16","author":[{"given":"Joseph","family":"Mendy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyin","family":"Togun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olumuyiwa","family":"Owolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Donkor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin O. C.","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne S.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"key":"1447_CR1","unstructured":"WHO Global Tuberculosis report 2014. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/ . Accessed at: on\u00a020th\u00a0October, 2015."},{"key":"1447_CR2","unstructured":"Medicins Sans Frontieres campaign for access to essential medicines 2009. Tuberculosis: New Faces of an Old Disease. https:\/\/www.msf.org.uk\/sites\/uk\/files\/2009_Tuberculosis__New_Faces_of_an_Old_Disease_200907240007.pdf . Accessed at: on 20th October, 2015."},{"key":"1447_CR3","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ng.2744","volume":"45","author":"I Comas","year":"2013","unstructured":"Comas I, Coscolla M, Luo T, Borrell S, Holt KE, Kato-Maeda M, Parkhill J, Malla B, Berg S, Thwaites G, Yeboah-Manu D, Bothamley G, Mei J, Wei L, Bentley S, Harris SR, Niemann S, Diel R, Aseffa A, Gao Q, Young D, Gagneux S. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet. 2013;45:1176\u201382.","journal-title":"Nat Genet"},{"key":"1447_CR4","doi-asserted-by":"crossref","unstructured":"Traore B, Diarra B, Dembele BP, Somboro AM, Hammond AS, Siddiqui S, Maiga M, Kone B, Sarro YS, Washington J, Parta M, Coulibaly N, M'baye O, Diallo S, Koita O, Tounkara A, Polis MA. Molecular strain typing of Mycobacterium tuberculosis complex in Bamako, Mali. Int J Tuberc Lung Dis. 2012;16:911\u20136.","DOI":"10.5588\/ijtld.11.0397"},{"key":"1447_CR5","first-page":"450","volume":"11","author":"BC Jong de","year":"2007","unstructured":"de Jong BC, Hill PC, Aiken A, Jeffries DJ, Onipede A, Small PM, Adegbola RA, Corrah TP. Clinical presentation and outcome of tuberculosis patients infected by M. africanum versus M. tuberculosis. Int J Tuberc Lung Dis. 2007;11:450\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1447_CR6","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3201\/eid1910.121023","volume":"19","author":"F Gehre","year":"2013","unstructured":"Gehre F, Antonio M, Otu JK, Sallah N, Secka O, Faal T, Owiafe P, Sutherland JS, Adetifa IM, Ota MO, Kampmann B, Corrah T, de Jong BC. Immunogenic Mycobacterium africanum strains associated with ongoing transmission in The Gambia. Emerg Infect Dis. 2013;19:1598\u2013604.","journal-title":"Emerg Infect Dis"},{"key":"1447_CR7","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/eji.201343956","volume":"44","author":"LD Tientcheu","year":"2014","unstructured":"Tientcheu LD, Sutherland JS, de Jong BC, Kampmann B, Jafali J, Adetifa IM, Antonio M, Dockrell HM, Ota MO. Differences in T-cell responses between Mycobacterium tuberculosis and Mycobacterium africanum-infected patients. Eur J Immunol. 2014;44:1387\u201398.","journal-title":"Eur J Immunol"},{"key":"1447_CR8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/gene.2015.21","volume":"16","author":"LD Tientcheu","year":"2015","unstructured":"Tientcheu LD, Maertzdorf J, Weiner J, Adetifa IM, Mollenkopf HJ, Sutherland JS, Donkor S, Kampmann B, Kaufmann SH, Dockrell HM, Ota MO. Differential transcriptomic and metabolic profiles of M. africanum- and M. tuberculosis-infected patients after, but not before, drug treatment. Genes Immun. 2015;16:347\u201355.","journal-title":"Genes Immun"},{"key":"1447_CR9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tube.2015.01.003","volume":"95","author":"V Clifford","year":"2015","unstructured":"Clifford V, Zufferey C, Street A, Denholm J, Tebruegge M, Curtis N. Cytokines for monitoring anti-tuberculous therapy: A systematic review. Tuberculosis (Edinb). 2015;95:217\u201384.","journal-title":"Tuberculosis (Edinb)"},{"key":"1447_CR10","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3113\/FAI.2012.0832","volume":"33","author":"\u0141 Dzieciuchowicz","year":"2012","unstructured":"Dzieciuchowicz \u0141, Kruszyna \u0141, Krasi\u0144ski Z, Espinosa G. Monitoring of systemic inflammatory response in diabetic patients with deep foot infection treated with negative pressure wound therapy. Foot Ankle Int. 2012;33:832\u20137.","journal-title":"Foot Ankle Int"},{"key":"1447_CR11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5588\/ijtld.13.0519","volume":"18","author":"PK Drain","year":"2014","unstructured":"Drain PK, Mayeza L, Bartman P, Hurtado R, Moodley P, Varghese S, Maartens G, Alvarez GG, Wilson D. Diagnostic accuracy and clinical role of rapid C-reactive protein testing in HIV-infected individuals with presumed tuberculosis in South Africa. Int J Tuberc Lung Dis. 2014;18:20\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1447_CR12","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.2500\/aap.2015.36.3816","volume":"36","author":"T Shimoda","year":"2015","unstructured":"Shimoda T, Obase Y, Kishikawa R, Iwanaga T. Serum high-sensitivity C-reactive protein can be an airway inflammation predictor in bronchial asthma. Allergy Asthma Proc. 2015;36:e23\u201328.","journal-title":"Allergy Asthma Proc"},{"key":"1447_CR13","first-page":"44","volume":"12","author":"RA Breen","year":"2008","unstructured":"Breen RA, Leonard O, Perrin FM, Smith CJ, Bhagani S, Cropley I, Lipman MC. How good are systemic symptoms and blood inflammatory markers at detecting individuals with tuberculosis? Int J Tuberc Lung Dis. 2008;12:44\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1447_CR14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1165\/ajrcmb\/6.6.639","volume":"6","author":"KC Meyer","year":"1992","unstructured":"Meyer KC, Cornwell R, Carlin JM, Powers C, Irizarry A, Byrne GI, Borden EC. Effects of interferons beta or gamma on neopterin biosynthesis and tryptophan degradation by human alveolar macrophages in vitro: synergy with lipopolysaccharide. Am J Respir Cell Mol Biol. 1992;6:639\u201346.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1447_CR15","first-page":"220","volume":"121","author":"C Immanuel","year":"2005","unstructured":"Immanuel C, Victor L, Chelvi KS, Padmapriyadarsini C, Rehman F, Iliayas S, Swaminathan S. Serum neopterin levels in HIV infected patients with & without tuberculosis. Indian J Med Res. 2005;121:220\u20135.","journal-title":"Indian J Med Res"},{"key":"1447_CR16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1620\/tjem.209.321","volume":"209","author":"T Turgut","year":"2006","unstructured":"Turgut T, Akbulut H, Deveci F, Kacar C, Muz MH. Serum interleukin-2 and neopterin levels as useful markers for treatment of active pulmonary tuberculosis. Tohoku J Exp Med. 2006;209:321\u20138.","journal-title":"Tohoku J Exp Med"},{"key":"1447_CR17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0731-7085(00)00550-1","volume":"24","author":"C Donadio","year":"2001","unstructured":"Donadio C, Lucchesi A, Ardini M, Giordani R. Cystatin C, beta 2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: comparison with plasma creatinine. J Pharm Biomed Anal. 2001;24:835\u201342.","journal-title":"J Pharm Biomed Anal"},{"key":"1447_CR18","doi-asserted-by":"crossref","unstructured":"Romero-S\u00e1nchez MC, Alvarez-R\u00edos AI, Bernal-Morell E, Genebat M, Vera F, Benhnia MR, et al. Maintenance of virologic efficacy and decrease in levels of \u03b22-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy. Antiviral Res. 2014;111:26\u201332.","DOI":"10.1016\/j.antiviral.2014.08.011"},{"key":"1447_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2249.2000.01341.x","volume":"122","author":"SD Lawn","year":"2000","unstructured":"Lawn SD, Rudolph D, Wiktor S, Coulibaly D, Ackah A, Lal RB. Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively. Clin Exp Immunol. 2000;122:79\u201384.","journal-title":"Clin Exp Immunol"},{"key":"1447_CR20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/00365549950163554","volume":"31","author":"J Collazos","year":"1999","unstructured":"Collazos J, Mart\u00ednez E, Mayo J. Evolution of serum beta2-microglobulin concentrations during treatment of tuberculosis patients. Scand J Infect Dis. 1999;31:265\u20137.","journal-title":"Scand J Infect Dis"},{"key":"1447_CR21","doi-asserted-by":"crossref","first-page":"e1004446","DOI":"10.1371\/journal.ppat.1004446","volume":"10","author":"G Sreejit","year":"2014","unstructured":"Sreejit G, Ahmed A, Parveen N, Jha V, Valluri VL, Ghosh S, Mukhopadhyay S. The ESAT-6 protein of Mycobacterium tuberculosis interacts with beta-2-microglobulin (\u03b22M) affecting antigen presentation function of macrophage. PLoS Pathog. 2014;10:e1004446.","journal-title":"PLoS Pathog"},{"key":"1447_CR22","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1183\/09031936.00114214","volume":"45","author":"CC Leung","year":"2015","unstructured":"Leung CC, Yew WW, Chan CK, Chang KC, Law WS, Lee SN, Tai LB, Leung EC, Au RK, Huang SS, Tam CM. Smoking adversely affects treatment response, outcome and relapse in tuberculosis. Eur Respir J. 2015;45:738\u201345.","journal-title":"Eur Respir J"},{"key":"1447_CR23","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1016\/j.vaccine.2015.08.084","volume":"33","author":"SA Marcus","year":"2015","unstructured":"Marcus SA, Steinberg H, Talaat AM. Protection by novel vaccine candidates, Mycobacterium tuberculosis \u0394mosR and \u0394echA7, against challenge with a Mycobacterium tuberculosis Beijing strain. Vaccine. 2015;33:5633\u20139.","journal-title":"Vaccine"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1447-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T03:50:16Z","timestamp":1498276216000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2334\/16\/115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,8]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1447"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1447-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,8]]},"article-number":"115"}}